Lancaster, OH, United States of America

Kevin Sanford Blythe



Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 116(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kevin Sanford Blythe: Innovator in Pulmonary Therapeutics

Introduction

Kevin Sanford Blythe is a notable inventor based in Lancaster, Ohio. He has made significant contributions to the field of pulmonary therapeutics, particularly through his innovative patent that addresses the delivery of respirable therapeutically active materials.

Latest Patents

Blythe holds a patent for a "Pulmonary dosing system and method." This invention provides a system for supplying a predetermined amount of respirable therapeutically active material to patients. The system includes a patient interface designed to introduce the material into the patient's lungs, along with an apparatus that delivers pulsed amounts of the material to a plenum chamber. The plenum chamber features a diffuser baffle that enhances the efficiency of the dosing system by preventing axial flow of the active material. This design utilizes the available volume of the chamber to hold aerosolized drugs prior to inhalation.

Career Highlights

Blythe is associated with Battelle Pulmonary Therapeutics, Inc., where he continues to develop and refine technologies aimed at improving patient outcomes in respiratory care. His work is characterized by a commitment to innovation and a focus on practical applications of his inventions.

Collaborations

Throughout his career, Blythe has collaborated with talented individuals such as Anthony Rocco Imondi and Daniel Duane Meek. These partnerships have contributed to the advancement of his projects and the overall mission of improving pulmonary health.

Conclusion

Kevin Sanford Blythe's contributions to pulmonary therapeutics through his innovative patent exemplify the impact of dedicated inventors in the medical field. His work continues to pave the way for advancements in respiratory treatment and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…